ArticleCureus2020

One-Year Follow-Up Study of Changes in Prostaglandin-Associated Periorbital Syndrome After Switch From Conventional Prostaglandin F2alfa to Omidenepag Isopropyl.

Satomi Oogi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.